Information About Risk Management & Crisis Response
Recent Posts
Below is a preview of the five most recent posts from the blog Risk Management & Crisis Response. To read these posts in their entirely or subscribe to future updates from this blog, please visit their website!
- So you’ve submitted your report under Canada’s Modern Slavery Act — now what? Best practices to ensure supply chain compliance
The first reporting deadline under Canada’s Fighting Against Forced Labour and Child Labour in Supply Chains Act (the Modern Slavery Act or the Act) has passed. Entities and government institutions subject to the reporting obligation under the Act were required to submit their first annual reports o … Read more »
- Ontario court finds police cannot circumvent Parliament’s tailor-made warrants for digital assets
As technology has evolved, Canadian authorities have grappled with novel challenges investigating and prosecuting financial crime, including those crimes involving cryptocurrency and other digital assets. Parties affected by these enforcement developments have included not only potential illicit act … Read more »
- Extension and clarifications on the regulation of value-referenced cryptoassets
In a notable development, the Canadian Securities Administrators (CSA) recently announced an extension to the compliance deadline for crypto trading platforms (CTPs) dealing with value-referenced cryptoassets (VRCAs), originally detailed in CSA Staff Notice 21-333, dated October 5, 2023 (October 202 … Read more »
- Budget 2024 proposes new reforms to combat financial crime in Canada
The federal government’s Budget [PDF] 2024, released on April 16, 2024, contains a number of initiatives and legislative reforms aimed at combatting financial crime in Canada, including terrorist financing, corruption, sanctions evasion, tax evasion, money laundering, and fraud. The Budget promises … Read more »
- SEC wins novel ‘shadow trading’ trial against biopharma executive
On April 5, 2024, the U.S. Securities and Exchange Commission (SEC) succeeded in its much-watched civil action against Matthew Panuwat, a former business development executive at Medivation Inc., a midcap biopharmaceutical company. The SEC’s complaint [PDF] raised a novel theory of insider trading k … Read more »